▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Taylor Carmichael

TMFSaintCroix

Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent Articles by Taylor Carmichael

Is_Novavax_Stock_a_Buy

Jun 26, 2021 by Taylor Carmichael

Is Novavax Stock a Buy?

The tiny biotech has had a magnificent run from $4 a share to $200. Can the stock run higher still?

Is_Novavax_s_COVID-19_Vaccine_Superior_to_the_mRNA_Vaccines

Jun 30, 2021 by Taylor Carmichael

Is Novavax's COVID-19 Vaccine Superior to the mRNA Vaccines?

All three vaccines have similar efficacy and safety profiles, but Novavax's vaccine might have a few advantages.

Why_Has_Novavax_Stock_Been_Jumping_Higher

Jun 25, 2021 by Taylor Carmichael

Why Has Novavax Stock Been Jumping Higher?

Positive phase 3 data and good news from the Biden administration have sent Novavax shares flying in June.

GettyImages-1289962301

Jun 24, 2021 by Taylor Carmichael

3 Top Stocks Under $10

Are you looking for cheap stocks with a lot of upside? Check out Rolls-Royce, Pieris Pharmaceuticals, and Kahoot!

GettyImages-696067380

Jun 18, 2021 by Taylor Carmichael

The Man Who Lost $265 Million

Many years ago Stefan Thomas was paid 7,002 bitcoins, and now he can't find his password.

GettyImages-450806655

Jun 17, 2021 by Taylor Carmichael

Is Investing Like Gambling?

There are similarities (you can lose money in both), but there are also some major differences.

GettyImages-1255592762

Jun 11, 2021 by Taylor Carmichael

Why This COVID-19 Stock Is On Fire Right Now

While vaccines and diagnostics have been the big winners in the space so far, Humanigen might make investors a lot of money with its drug to treat cytokine storms caused by COVID-19.

GettyImages-1269894068

Jun 9, 2021 by Taylor Carmichael

Up 100% in a Year, Can This Animal Health Stock Keep Climbing?

Not only has Heska stock doubled in a year, it has quintupled over the past five years, and it's a 20-bagger over the last decade. Why is this animal health stock flying so high?

GettyImages-1204596250

Jun 8, 2021 by Taylor Carmichael

Why Online Ordering Is Huge for the Restaurant Industry

We're seeing a massive shift in the trillion-dollar restaurant industry, as more and more sales come from delivery and takeout. Olo, the software solution for the restaurant industry, will likely benefit from these trends.

GettyImages-1298875724

Jun 4, 2021 by Taylor Carmichael

Novavax Stock Spikes as U.S. Releases Hold on Raw Materials for COVID-19 Vaccines

Novavax stock has jumped 30% this week in anticipation of dramatically increasing production of its COVID-19 vaccine soon.

GettyImages-1297185151 (1)

May 30, 2021 by Taylor Carmichael

Could Nano-X Be a Millionaire-Maker Stock?

Nano-X is not a safe investment -- it's a highly risky one. But its potential upside is incredible.

Will_Amazon_or_Walmart_Acquire_Teladoc-1

Jun 26, 2021 by Taylor Carmichael

Will Amazon or Walmart Acquire Teladoc?

These two retailing giants want to enter the healthcare field. Does that make Teladoc an acquisition candidate?

Will_Health_Insurers_Start_Competing_With_Teladoc

Jun 29, 2021 by Taylor Carmichael

Will Health Insurers Start Competing With Teladoc?

Teladoc's amazing success in virtual healthcare has caused other healthcare companies to want to enter the market with their own solution. Even some insurance companies are getting in on the act.

How_Amazon_Might_Defeat_Teladoc_Health

Jun 26, 2021 by Taylor Carmichael

How Amazon Might Defeat Teladoc Health

Currently Amazon is shopping its Amazon health insurance to corporate clients. But what happens if Amazon starts competing with Teladoc directly?

How_Valuable_is_Teladoc_s_First_Mover_Advantage

Jun 29, 2021 by Taylor Carmichael

How Valuable Is Teladoc's First-Mover Advantage?

Amazon and Walmart are about to find out.

Are_Walmart_and_Amazon_A_Threat_to_Teladoc

Jun 26, 2021 by Taylor Carmichael

Are Walmart and Amazon a Threat to Teladoc?

Back in the 20th century, a lot of people thought that massive Walmart would move online and crush Amazon. But it's not easy to crush a top dog and first mover in a new emerging industry.

Here_s_Why_Moderna_Doesn_t_Need_IP_Protection_for_Its_COVID-19_Vaccine

Jun 26, 2021 by Taylor Carmichael

Here's Why Moderna Doesn't Need IP Protection for Its COVID-19 Vaccine

Moderna waived its IP rights in its vaccine candidate last year. But no company has tried to make a generic version of its mRNA vaccine.

Is_COMPASS_Pathways_a_Buy

Jun 26, 2021 by Taylor Carmichael

Is Compass Pathways a Buy?

The biotech is developing a treatment paradigm combining talk therapy with a purified version of psilocybin, the active ingredient in "magic mushrooms." Will this be a money-maker?

Can_Psychedelics_Actually_Cure_Depression_and_PTSD

Jun 26, 2021 by Taylor Carmichael

Can Psychedelics Actually Cure Depression and PTSD?

There is now data suggesting that magic mushrooms and ecstasy -- combined with talk therapy -- may help people with severe depression and post-traumatic stress disorder.

Has_Novavax_Lost_the_Vaccine_Race_to_Moderna

Jun 26, 2021 by Taylor Carmichael

Has Novavax Lost the Vaccine Race to Moderna?

Moderna and Pfizer got their COVID-19 vaccines to market fast. Will there be any opportunity left for Novavax to win market share?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services